Most of the patients I see for the first time have already tried something. An SSRI from a primary care doctor, maybe a second one after the first didn’t help, sometimes a combination prescribed by a previous psychiatrist. By the time they sit down across from me, they’re often exhausted — not just by depression itself, but by the process of trying to treat it.
If that sounds familiar, you may be dealing with what’s clinically termed treatment-resistant depression, or TRD. It’s a more common situation than people realize, and it doesn’t mean you’re out of options.
What treatment-resistant depression actually means
The clinical definition is fairly specific: depression that hasn’t adequately improved after trying two or more antidepressants, from different classes, at adequate doses, for an adequate length of time — typically at least six to eight weeks each. It’s not a judgment about how hard you’ve tried, and it’s not a different illness from depression. It’s a description of where standard treatment has left off.
In my experience, a TRD diagnosis often says as much about the treatment process as it does about the depression itself. Medications get stopped too early, doses never quite reach a therapeutic level, or a medication that’s wrong for a particular person’s biology gets tried for months before anyone reconsiders the approach.
Why this happens
- Depression isn’t one condition with one mechanism — different people respond to different medication classes for reasons we don’t fully understand
- Underlying factors like thyroid issues, sleep disorders, or substance use can blunt a medication’s effectiveness if they go unaddressed
- Doses are sometimes increased too slowly, or stopped before they’ve had a real chance to work
- Co-occurring anxiety, trauma history, or bipolar spectrum features can complicate a straightforward depression diagnosis
This is part of why I spend so much time on history at a first visit. A treatment-resistant label is sometimes accurate, and sometimes it’s a sign that something in the picture hasn’t been looked at closely enough yet.
What I look at first
Before considering newer treatment options, I review the full medication history in detail — what was tried, at what dose, for how long, and what specifically did or didn’t change. I also screen for medical conditions that mimic or worsen depression, ask carefully about alcohol and substance use, and consider whether the original diagnosis was the right one. Bipolar II, in particular, is frequently missed and treated as straightforward depression for years.
Sometimes the next step is simply optimizing what’s already been tried — a dose adjustment, a longer trial, or a combination strategy that hasn’t been attempted. Other times, it’s clear that a different category of treatment is warranted.
Options beyond standard antidepressants
When two or more adequate trials genuinely haven’t worked, several evidence-based paths exist:
- Medication combination or augmentation — adding a second agent to an existing antidepressant, rather than switching entirely
- Spravato® (esketamine) — an FDA-approved nasal spray for treatment-resistant depression, administered in-office under medical supervision
- Transcranial magnetic stimulation (TMS) — a non-medication option using magnetic pulses to stimulate areas of the brain involved in mood regulation
- Psychotherapy alongside medication — particularly when trauma, grief, or relational patterns are part of what’s sustaining the depression
None of these are universal solutions, and a careful evaluation is what determines which path actually fits your situation — not a standard protocol applied the same way to everyone.
If this sounds like where you are
Treatment-resistant depression can feel like a dead end, especially after multiple attempts that haven’t worked. In practice, it’s usually the point where a more thorough look — at history, at diagnosis, at options that haven’t been tried — tends to matter most. That review is where I’d want to start.